Skip to content
Boost Up Blog – Lifestyle
Author:
Vantage Biosciences
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy
August 4, 2026